CVE-2023-38956 :: Enginsight Vulnerability Database

Provider	Type	Base Score	Atk. Vector	Atk. Complexity	Priv. Required	Vector
NIST	Primary	7.5 HIGH	NETWORK	LOW	NONE	CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N

Base Score

CVSS 3.x

EPSS Score

Percentile: 50%

Affected Products (NVD)

Vendor	Product	Version
zkteco	bioaccess_ivs	3.3.1

𝑥

= Vulnerable software versions

Common Weakness Enumeration

CWE-22 - Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal')
The software uses external input to construct a pathname that is intended to identify a file or directory that is located underneath a restricted parent directory, but the software does not properly neutralize special elements within the pathname that can cause the pathname to resolve to a location that is outside of the restricted directory.

References

http://zkteco.com

https://claroty.com/team82/disclosure-dashboard/cve-2023-38956

http://zkteco.com

https://claroty.com/team82/disclosure-dashboard/cve-2023-38956